Login to Your Account



Private Equity Component: $300M

Ikaria And INO Therapeutics Join Forces In $670M Merger

By Trista Morrison


Friday, February 23, 2007
In a merger valued at $670 million, Seattle-based biotech Ikaria Inc. is joining forces with Clinton, N.J.-based INO Therapeutics Inc., the specialty pharmaceutical division of The Linde Group. The new company, Ikaria Holdings, will focus on gas-based critical care therapeutics. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription